Well not bad at all considering the downfall we had seen during FDA turmoil. Very much welcome numbers. IT shows consistency and help improve confidence in script. Combining it with another launch if lenzetto product, it must be a BUY.
- Forums
- ASX - By Stock
- Q4 Axiron Sales
Well not bad at all considering the downfall we had seen during...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.8¢ |
Change
0.003(5.45%) |
Mkt cap ! $16.86M |
Open | High | Low | Value | Volume |
5.4¢ | 5.8¢ | 5.4¢ | $7.047K | 123.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 22861 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 17257 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 22861 | 0.056 |
1 | 37735 | 0.053 |
1 | 168669 | 0.052 |
3 | 119539 | 0.051 |
2 | 217490 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 17257 | 1 |
0.060 | 670 | 1 |
0.061 | 100000 | 1 |
0.062 | 116100 | 2 |
0.063 | 111500 | 2 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |